 6. Recovery from any drug-related adverse event derived from any previous treatment, excluding alopecia and grade 1 asymptomatic peripheral neuropathy according to the National Cancer Institute-Common Terminology Criteria for Adverse Events NCI-CTCAE v.3.0. 